poisar

Stocks · News reference

Baird Maintains Neutral on AMETEK, Raises Price Target to $280

BenzingaBenzinga Newsdesk

Baird analyst Quinn Fredrickson maintains AMETEK (NYSE:AME) with a Neutral and raises the price target from $275 to $280.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncResearchandmarkets.Com

    Veterinary Ophthalmology Equipment Market by Product, Animal Type, Application, End User, Region Report Forecasts Market to Reach USD 0.83 Billion by 2031, Growing at a 7.7% CAGR

    The global veterinary ophthalmology equipment market is expected to grow from USD 0.57 billion in 2026 to USD 0.83 billion by 2031, at a 7.7% CAGR. Growth is driven by rising pet ownership, increased prevalence of animal eye diseases, and adoption of advanced diagnostic and surgical technologies. Treatment applications and surgical equipment segments are leading growth, with Asia Pacific emerging as the fastest-growing region.

  2. The Motley FoolJames Brumley

    NASA's New Moon Base Contract Could Be an Out-of-This-World Opportunity for This Under-the-Radar Nuclear Power Stock

    NASA is seeking proposals for a lunar base power system, including a Stirling radioisotope generator. Ametek's subsidiary Sunpower has already developed and proven a working prototype for NASA that has operated for over 17 years, positioning the company well to win this contract and leverage the technology for future space missions.